Annual EPS
-$1.89
+$0.60+24.10%
December 31, 2023
Summary
- As of February 7, 2025, IOVA annual earnings per share is -$1.89, with the most recent change of +$0.60 (+24.10%) on December 31, 2023.
- During the last 3 years, IOVA annual EPS has fallen by -$0.01 (-0.53%).
Performance
IOVA EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.28
+$0.06+17.65%
September 30, 2024
Summary
- As of February 7, 2025, IOVA quarterly earnings per share is -$0.28, with the most recent change of +$0.06 (+17.65%) on September 30, 2024.
- Over the past year, IOVA quarterly EPS has increased by +$0.14 (+33.33%).
- IOVA quarterly EPS is now -106.19% below its all-time high of $4.52, reached on December 31, 2012.
Performance
IOVA Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$1.49
+$0.18+10.78%
September 30, 2024
Summary
- As of February 7, 2025, IOVA TTM earnings per share is -$1.49, with the most recent change of +$0.18 (+10.78%) on September 30, 2024.
- Over the past year, IOVA TTM EPS has increased by +$0.31 (+17.22%).
- IOVA TTM EPS is now -175.94% below its all-time high of $1.96, reached on March 31, 2013.
Performance
IOVA TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
IOVA EPS Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +24.1% | +33.3% | +17.2% |
3 y3 years | -0.5% | +55.6% | +37.7% |
5 y5 years | -48.8% | +55.6% | +37.7% |
IOVA EPS Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +24.1% | at high | +56.3% | at high | +39.9% |
5 y | 5-year | -18.9% | +24.1% | at high | +56.3% | at high | +39.9% |
alltime | all time | <-9999.0% | +94.4% | -106.2% | +98.1% | -175.9% | +96.3% |
Iovance Biotherapeutics EPS History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$0.28(-17.6%) | -$1.49(-10.8%) |
Jun 2024 | - | -$0.34(-19.0%) | -$1.67(-7.2%) |
Mar 2024 | - | -$0.42(-6.7%) | -$1.80(-4.3%) |
Dec 2023 | -$1.89(-24.1%) | -$0.45(-2.2%) | -$1.88(-9.2%) |
Sep 2023 | - | -$0.46(-2.1%) | -$2.07(-7.6%) |
Jun 2023 | - | -$0.47(-6.0%) | -$2.24(-6.7%) |
Mar 2023 | - | -$0.50(-21.9%) | -$2.40(-3.2%) |
Dec 2022 | -$2.49(+11.7%) | -$0.64(+1.6%) | -$2.48(+0.4%) |
Sep 2022 | - | -$0.63(0.0%) | -$2.47(+3.3%) |
Jun 2022 | - | -$0.63(+8.6%) | -$2.39(+4.4%) |
Mar 2022 | - | -$0.58(-7.9%) | -$2.29(+3.2%) |
Dec 2021 | -$2.23(+18.6%) | -$0.63(+14.5%) | -$2.22(+7.8%) |
Sep 2021 | - | -$0.55(+3.8%) | -$2.06(+7.9%) |
Jun 2021 | - | -$0.53(+3.9%) | -$1.91(+3.2%) |
Mar 2021 | - | -$0.51(+8.5%) | -$1.85(-2.1%) |
Dec 2020 | -$1.88(+18.2%) | -$0.47(+17.5%) | -$1.89(-1.6%) |
Sep 2020 | - | -$0.40(-14.9%) | -$1.92(0.0%) |
Jun 2020 | - | -$0.47(-14.5%) | -$1.92(+4.9%) |
Mar 2020 | - | -$0.55(+10.0%) | -$1.83(+15.8%) |
Dec 2019 | -$1.59(+25.2%) | -$0.50(+25.0%) | -$1.58(+17.0%) |
Sep 2019 | - | -$0.40(+5.3%) | -$1.35(+3.1%) |
Jun 2019 | - | -$0.38(+26.7%) | -$1.31(+3.1%) |
Mar 2019 | - | -$0.30(+11.1%) | -$1.27(-0.8%) |
Dec 2018 | -$1.27(-9.9%) | -$0.27(-25.0%) | -$1.28(-6.6%) |
Sep 2018 | - | -$0.36(+5.9%) | -$1.37(+0.7%) |
Jun 2018 | - | -$0.34(+9.7%) | -$1.36(-2.2%) |
Mar 2018 | - | -$0.31(-13.9%) | -$1.39(-1.4%) |
Dec 2017 | -$1.41(-23.8%) | -$0.36(+2.9%) | -$1.41(+8.5%) |
Sep 2017 | - | -$0.35(-5.4%) | -$1.30(-38.1%) |
Jun 2017 | - | -$0.37(+12.1%) | -$2.10(+7.1%) |
Mar 2017 | - | -$0.33(+32.0%) | -$1.96(+10.7%) |
Dec 2016 | -$1.85 | -$0.25(-78.3%) | -$1.77(+2.9%) |
Sep 2016 | - | -$1.15(+400.0%) | -$1.72(+135.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2016 | - | -$0.23(+64.3%) | -$0.73(+14.1%) |
Mar 2016 | - | -$0.14(-30.0%) | -$0.64(0.0%) |
Dec 2015 | -$0.62(+29.2%) | -$0.20(+25.0%) | -$0.64(+3.2%) |
Sep 2015 | - | -$0.16(+14.3%) | -$0.62(+8.8%) |
Jun 2015 | - | -$0.14(0.0%) | -$0.57(+9.6%) |
Mar 2015 | - | -$0.14(-22.2%) | -$0.52(+6.1%) |
Dec 2014 | -$0.48(-86.2%) | -$0.18(+63.6%) | -$0.49(-62.5%) |
Sep 2014 | - | -$0.11(+22.2%) | -$1.31(-29.6%) |
Jun 2014 | - | -$0.09(-18.2%) | -$1.86(-68.8%) |
Mar 2014 | - | -$0.11(-89.0%) | -$5.96(-16.4%) |
Dec 2013 | -$3.47(-16.2%) | -$1.00(+51.0%) | -$7.13(+342.7%) |
Sep 2013 | - | -$0.66(-84.2%) | -$1.61(-11.0%) |
Jun 2013 | - | -$4.19(+227.3%) | -$1.81(-192.3%) |
Mar 2013 | - | -$1.28(-128.3%) | $1.96(-147.3%) |
Dec 2012 | -$4.14(-87.8%) | $4.52(-625.6%) | -$4.15(-78.9%) |
Sep 2012 | - | -$0.86(+105.7%) | -$19.67(-23.8%) |
Jun 2012 | - | -$0.42(-94.3%) | -$25.81(-36.1%) |
Mar 2012 | - | -$7.39(-32.8%) | -$40.39(+18.8%) |
Dec 2011 | -$34.00(+1600.0%) | -$11.00(+57.1%) | -$34.00(+41.6%) |
Sep 2011 | - | -$7.00(-53.3%) | -$24.01(+33.3%) |
Jun 2011 | - | -$15.00(+1400.0%) | -$18.01(+498.8%) |
Mar 2011 | - | -$1.00(-0.7%) | -$3.01(+49.8%) |
Dec 2010 | -$2.00(<-9900.0%) | -$1.01(+0.8%) | -$2.01(+100.1%) |
Sep 2010 | - | -$1.00(<-9900.0%) | -$1.00(>+9900.0%) |
Jun 2010 | - | $0.00(0.0%) | -$0.00(0.0%) |
Mar 2010 | - | $0.00(-100.0%) | -$0.00(0.0%) |
Dec 2009 | $0.00(-100.0%) | -$0.00(<-9900.0%) | -$0.00(-99.7%) |
Sep 2009 | - | $0.00(0.0%) | -$1.00(0.0%) |
Jun 2009 | - | $0.00(0.0%) | -$1.00(0.0%) |
Mar 2009 | - | $0.00(-100.0%) | -$1.00(0.0%) |
Dec 2008 | -$1.00 | -$1.00(<-9900.0%) | -$1.00(<-9900.0%) |
Sep 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2008 | - | $0.00 | $0.00 |
FAQ
- What is Iovance Biotherapeutics annual earnings per share?
- What is the all time high annual EPS for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics annual EPS year-on-year change?
- What is Iovance Biotherapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly EPS year-on-year change?
- What is Iovance Biotherapeutics TTM earnings per share?
- What is the all time high TTM EPS for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics TTM EPS year-on-year change?
What is Iovance Biotherapeutics annual earnings per share?
The current annual EPS of IOVA is -$1.89
What is the all time high annual EPS for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual earnings per share is $0.00
What is Iovance Biotherapeutics annual EPS year-on-year change?
Over the past year, IOVA annual earnings per share has changed by +$0.60 (+24.10%)
What is Iovance Biotherapeutics quarterly earnings per share?
The current quarterly EPS of IOVA is -$0.28
What is the all time high quarterly EPS for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly earnings per share is $4.52
What is Iovance Biotherapeutics quarterly EPS year-on-year change?
Over the past year, IOVA quarterly earnings per share has changed by +$0.14 (+33.33%)
What is Iovance Biotherapeutics TTM earnings per share?
The current TTM EPS of IOVA is -$1.49
What is the all time high TTM EPS for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high TTM earnings per share is $1.96
What is Iovance Biotherapeutics TTM EPS year-on-year change?
Over the past year, IOVA TTM earnings per share has changed by +$0.31 (+17.22%)